4.3 Review

On the origin of myeloid-derived suppressor cells

Journal

ONCOTARGET
Volume 8, Issue 2, Pages 3649-3665

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.12278

Keywords

MDSC origin; myelopoiesis; emergency myelopoiesis; reprogramming; extramedullary

Funding

  1. Vetenskapsradet
  2. Cancerfonden
  3. Osterlunds Foundation
  4. Gunnar Nilsson Cancer Foundation
  5. MAS Cancer Foundation
  6. Ake Wibergs Foundation

Ask authors/readers for more resources

Myeloid-derived suppressor cells (MDSCs) have a strong immunosuppressive character that allows them to regulate immune responses and hinder overt inflammatory responses. In cancer, this leads to tumor immune evasion and disease progression. MDSCs come in at least two forms: monocytic (Mo-MDSCs) and granulocytic (G-MDSCs). The classical definition of MDSCs as immature myeloid cells blocked from differentiating has been challenged by recent studies suggesting that Mo-MDSCs and G-MDSCs may represent monocytes and granulocytes that have acquired immunosuppressive properties. The molecular mechanism behind their generation and their true origins are now widely debated. In this review we discuss the different proposed mechanisms of the generation of both types of MDSCs, with a special focus on human MDSCs in cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available